TrialStem cell research & therapy2024

Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study.

Yingqian Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.